Dopaminergic denervation and associated MRI microstructural changes in the nigrostriatal projection in early Parkinson's disease patients.


Journal

NPJ Parkinson's disease
ISSN: 2373-8057
Titre abrégé: NPJ Parkinsons Dis
Pays: United States
ID NLM: 101675390

Informations de publication

Date de publication:
19 Oct 2023
Historique:
received: 20 02 2023
accepted: 03 10 2023
medline: 19 10 2023
pubmed: 19 10 2023
entrez: 18 10 2023
Statut: epublish

Résumé

Loss of dopaminergic neurons in the substantia nigra pars compacta (SNc) and a profound reduction of striatal dopamine are two hallmarks of Parkinson's disease (PD). However, it's unclear whether degeneration starts at the neuronal soma or the striatal presynaptic terminals, and how microstructural degeneration is linked to dopaminergic loss is also uncertain. In this study, thirty de novo PD patients and twenty healthy subjects (HS) underwent 6-[

Identifiants

pubmed: 37852988
doi: 10.1038/s41531-023-00586-x
pii: 10.1038/s41531-023-00586-x
pmc: PMC10584921
doi:

Types de publication

Journal Article

Langues

eng

Pagination

144

Informations de copyright

© 2023. Springer Nature Limited.

Références

Neurobiol Aging. 2015 Feb;36(2):1097-104
pubmed: 25467638
Nat Rev Neurosci. 2022 Feb;23(2):115-128
pubmed: 34907352
Neuron. 2018 Sep 19;99(6):1116-1128
pubmed: 30236282
Prog Neurobiol. 2017 Aug;155:96-119
pubmed: 26455458
NMR Biomed. 2002 Nov-Dec;15(7-8):435-55
pubmed: 12489094
Sci Data. 2018 Apr 17;5:180063
pubmed: 29664465
Brain. 2022 Jun 30;145(6):2092-2107
pubmed: 35245368
Cereb Cortex. 2006 Feb;16(2):149-61
pubmed: 15858164
Neurobiol Dis. 2008 Mar;29(3):381-90
pubmed: 18226536
Mov Disord. 2019 Oct;34(10):1406-1422
pubmed: 31483900
Radiology. 2010 Nov;257(2):455-62
pubmed: 20843991
Brain. 2017 Aug 1;140(8):2183-2192
pubmed: 28899020
Mov Disord. 2022 Aug;37(8):1654-1662
pubmed: 35614551
PLoS One. 2016 Sep 06;11(9):e0162460
pubmed: 27598250
AJNR Am J Neuroradiol. 2016 May;37(5):782-8
pubmed: 26822728
Magn Reson Med. 2009 Sep;62(3):717-30
pubmed: 19623619
NPJ Parkinsons Dis. 2021 Jul 8;7(1):57
pubmed: 34238927
Neuroimage. 2019 Jan 15;185:379-387
pubmed: 30292815
J Neurosci Methods. 2016 May 1;264:47-56
pubmed: 26945974
Magn Reson Med. 2015 Feb;73(2):843-50
pubmed: 24664497
Brain. 2021 Jun 22;144(5):1488-1497
pubmed: 33880500
Brain. 2013 Aug;136(Pt 8):2419-31
pubmed: 23884810
Elife. 2017 Aug 21;6:
pubmed: 28826495
Front Neurosci. 2021 Feb 18;15:618435
pubmed: 33679303
PLoS One. 2013 Sep 03;8(9):e73021
pubmed: 24019889
Parkinsonism Relat Disord. 2015 Jun;21(6):590-6
pubmed: 25825242
PLoS One. 2020 May 29;15(5):e0233645
pubmed: 32469944
Mov Disord. 2018 May;33(5):678-683
pubmed: 29603370
Brain. 1999 Aug;122 ( Pt 8):1437-48
pubmed: 10430830
Front Neurol. 2020 May 28;11:366
pubmed: 32547468
Mov Disord. 2018 Apr;33(4):592-599
pubmed: 29436751
AJNR Am J Neuroradiol. 2015 Jun;36(6):1102-8
pubmed: 25767187
Mov Disord. 2012 Jan;27(1):90-7
pubmed: 21850668
J Parkinsons Dis. 2016 Oct 19;6(4):703-707
pubmed: 27497486
Hum Brain Mapp. 2017 Jul;38(7):3704-3722
pubmed: 28470878
J Nucl Med. 2014 Jan;55(1):73-9
pubmed: 24287322
Acta Neuropathol. 1992;83(4):352-60
pubmed: 1374203
Exp Neurol. 2017 Dec;298(Pt B):148-161
pubmed: 28987461
N Engl J Med. 1988 Apr 7;318(14):876-80
pubmed: 3352672
J Nucl Med. 2012 Mar;53(3):399-406
pubmed: 22323779
Neuropathol Appl Neurobiol. 2022 Aug;48(5):e12812
pubmed: 35274336
Hum Brain Mapp. 2002 Nov;17(3):143-55
pubmed: 12391568
Neuroimage. 2003 Oct;20(2):870-88
pubmed: 14568458
J Neurochem. 2014 Jun;129(6):898-915
pubmed: 24548101
Neuroimage. 2012 Aug 15;62(2):782-90
pubmed: 21979382
Front Neurol. 2020 Sep 25;11:531993
pubmed: 33101169
Brain. 1991 Oct;114 ( Pt 5):2283-301
pubmed: 1933245
J Parkinsons Dis. 2016;6(1):1-15
pubmed: 27003783
Mov Disord. 2009 Apr 15;24(5):723-30
pubmed: 19133661
Brain. 2021 Nov 29;144(10):3114-3125
pubmed: 33978742
Front Neuroinform. 2014 Feb 21;8:8
pubmed: 24600385
Hum Brain Mapp. 2019 Dec 1;40(17):5094-5107
pubmed: 31403737
J Neurol Neurosurg Psychiatry. 1999 Jun;66(6):754-8
pubmed: 10329749
Brain. 2022 Apr 29;145(3):1018-1028
pubmed: 35349639
Neuroimage Clin. 2017 Mar 27;14:734-740
pubmed: 28409113
Hum Brain Mapp. 2020 Apr 1;41(5):1323-1333
pubmed: 31778276
Neuroimage. 2004;23 Suppl 1:S208-19
pubmed: 15501092
J Neurosci. 2000 Mar 15;20(6):2369-82
pubmed: 10704511
Magn Reson Med. 2011 Sep;66(3):777-83
pubmed: 21465541
IEEE Trans Med Imaging. 2010 Jun;29(6):1310-20
pubmed: 20378467
Mov Disord. 2009 May 15;24(7):1009-15
pubmed: 19260097
Neuroimage. 2002 Oct;17(2):825-41
pubmed: 12377157
Sci Rep. 2018 Oct 30;8(1):16027
pubmed: 30375444
Parkinsonism Relat Disord. 2017 Nov;44:23-27
pubmed: 28838722
J Neurosci. 2009 Jan 14;29(2):444-53
pubmed: 19144844
Med Image Anal. 2008 Feb;12(1):26-41
pubmed: 17659998
Eur Radiol. 2016 Aug;26(8):2567-77
pubmed: 26515546
J Cereb Blood Flow Metab. 1983 Mar;3(1):1-7
pubmed: 6822610
Parkinsonism Relat Disord. 2019 May;62:10-15
pubmed: 30639168
Neuroimage. 2011 Jun 1;56(3):907-22
pubmed: 21352927
Neuroimage. 2011 Feb 1;54(3):2033-44
pubmed: 20851191
Mov Disord. 2006 Jul;21(7):958-63
pubmed: 16550545
J Nucl Med. 2015 Jul;56(7):1061-6
pubmed: 26025957
Brain. 2016 Feb;139(Pt 2):495-508
pubmed: 26705348
Parkinsonism Relat Disord. 2019 Aug;65:146-152
pubmed: 31182373
Neuroimage. 2016 Jan 15;125:1063-1078
pubmed: 26481672
Brain. 2019 Jul 1;142(7):2023-2036
pubmed: 31056699
Mov Disord. 2021 Apr;36(4):905-915
pubmed: 33471950
NMR Biomed. 2017 Apr;30(4):
pubmed: 26853890
Mov Disord. 2019 Sep;34(9):1274-1278
pubmed: 31136023
Ann Neurol. 2017 Dec;82(6):873-882
pubmed: 29165839
Parkinsonism Relat Disord. 2020 Dec;81:140-143
pubmed: 33130476
Ann Neurol. 2010 Jun;67(6):715-25
pubmed: 20517933
JAMA Neurol. 2014 Jun;71(6):758-66
pubmed: 24756323
J Neurol Sci. 1973 Dec;20(4):415-55
pubmed: 4272516
Front Neuroanat. 2011 Apr 20;5:26
pubmed: 21541304
Mov Disord. 2022 Oct;37(10):2057-2065
pubmed: 35765711
J Neurochem. 2008 Aug;106(4):1866-75
pubmed: 18624918

Auteurs

M López-Aguirre (M)

HM CINAC (Centro Integral de Neurociencias Abarca Campal). Hospital Universitario HM Puerta del Sur, HM Hospitales, Madrid, Spain.
PhD Program in Physics, Complutense University of Madrid, Madrid, Spain.
Centro de Investigación Biomédica en Red de Enfermedades Neurodegenerativas (CIBERNED), Instituto de Salud Carlos III, Madrid, Spain.
Aligning Science Across Parkinson's (ASAP) Collaborative Research Network, Chevy Chase, MD, 20815, USA.

M Matarazzo (M)

HM CINAC (Centro Integral de Neurociencias Abarca Campal). Hospital Universitario HM Puerta del Sur, HM Hospitales, Madrid, Spain.
Centro de Investigación Biomédica en Red de Enfermedades Neurodegenerativas (CIBERNED), Instituto de Salud Carlos III, Madrid, Spain.

J Blesa (J)

HM CINAC (Centro Integral de Neurociencias Abarca Campal). Hospital Universitario HM Puerta del Sur, HM Hospitales, Madrid, Spain.
Centro de Investigación Biomédica en Red de Enfermedades Neurodegenerativas (CIBERNED), Instituto de Salud Carlos III, Madrid, Spain.
Aligning Science Across Parkinson's (ASAP) Collaborative Research Network, Chevy Chase, MD, 20815, USA.

M H G Monje (MHG)

HM CINAC (Centro Integral de Neurociencias Abarca Campal). Hospital Universitario HM Puerta del Sur, HM Hospitales, Madrid, Spain.
Ken and Ruth Davee Department of Neurology, Northwestern University, Feinberg School of Medicine, Chicago, IL, USA.

R Rodríguez-Rojas (R)

HM CINAC (Centro Integral de Neurociencias Abarca Campal). Hospital Universitario HM Puerta del Sur, HM Hospitales, Madrid, Spain.
Centro de Investigación Biomédica en Red de Enfermedades Neurodegenerativas (CIBERNED), Instituto de Salud Carlos III, Madrid, Spain.

A Sánchez-Ferro (A)

HM CINAC (Centro Integral de Neurociencias Abarca Campal). Hospital Universitario HM Puerta del Sur, HM Hospitales, Madrid, Spain.
Centro de Investigación Biomédica en Red de Enfermedades Neurodegenerativas (CIBERNED), Instituto de Salud Carlos III, Madrid, Spain.
Department of Neurology, University Hospital 12 de Octubre, Madrid, Spain.
Department of Medicine, Complutense University of Madrid, Madrid, Spain.

J A Obeso (JA)

HM CINAC (Centro Integral de Neurociencias Abarca Campal). Hospital Universitario HM Puerta del Sur, HM Hospitales, Madrid, Spain.
Centro de Investigación Biomédica en Red de Enfermedades Neurodegenerativas (CIBERNED), Instituto de Salud Carlos III, Madrid, Spain.
Aligning Science Across Parkinson's (ASAP) Collaborative Research Network, Chevy Chase, MD, 20815, USA.
University CEU-San Pablo, Madrid, Spain.

J A Pineda-Pardo (JA)

HM CINAC (Centro Integral de Neurociencias Abarca Campal). Hospital Universitario HM Puerta del Sur, HM Hospitales, Madrid, Spain. jpineda.hmcinac@hmhospitales.com.
Centro de Investigación Biomédica en Red de Enfermedades Neurodegenerativas (CIBERNED), Instituto de Salud Carlos III, Madrid, Spain. jpineda.hmcinac@hmhospitales.com.
Aligning Science Across Parkinson's (ASAP) Collaborative Research Network, Chevy Chase, MD, 20815, USA. jpineda.hmcinac@hmhospitales.com.
University CEU-San Pablo, Madrid, Spain. jpineda.hmcinac@hmhospitales.com.

Classifications MeSH